Similar Articles
991 Application of gemstone spectral imaging for efficacy evaluation in hepatocellular carcinoma after transarterial chemoembolization
992 Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment
993 Epigenetic regulation of insulin-like growth factor axis in hepatocellular carcinoma
994 Impact of non-oncological factors on tumor recurrence after liver transplantation in hepatocellular carcinoma patients
995 Importance of SALL4 in the development and prognosis of hepatocellular carcinoma
996 Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play
997 Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma
998 Does autologous blood transfusion during liver transplantation for hepatocellular carcinoma increase risk of recurrence?
999 Hepatocellular carcinoma: Where are we?
1000 Blood DNA methylation markers in prospectively identified hepatocellular carcinoma cases and controls from Taiwan
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA